Literature DB >> 15654899

Serum IgM, IgG and IgA block by F(ab')-dependent mechanism the binding of natural IgG autoantibodies from therapeutic immunoglobulin preparations to self-antigens.

Iglika K Djoumerska1, Andrey I Tchorbanov, Vladimira D Donkova-Petrini, Anastas D Pashov, Tchavdar L Vassilev.   

Abstract

Natural polyreactive IgG autoantibodies are present in the plasma of healthy individuals and as a result in pooled therapeutic intravenous immunoglobulin (i.v.Ig) preparations. The spectrum of self-antigens to which these autoantibodies bind, their fate after intravenous infusion and their biological activity are not well understood. The identity of serum proteins that mask binding of natural autoantibodies to self-proteins is a matter of controversy. The spectrum of native serum proteins bound by i.v.Ig was analyzed by two-dimensional electrophoresis. The reactivity of i.v.Ig was directed mainly to circulating immunoglobulins. The binding of the IgG autoantibodies from i.v.Ig to native human liver antigens was blocked not only by a F(ab')2-dependent mechanism by circulating IgM and IgG (as has been previously suggested), but also by serum IgA. This control of anti-self reactivity may be inefficient in some autoimmune diseases. (c) Blackwell Munksgaard 2005

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654899     DOI: 10.1111/j.1600-0609.2004.00350.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  2 in total

1.  Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block.

Authors:  John G Routsias; Nikolaos C Kyriakidis; Deborah M Friedman; Carolina Llanos; Robert Clancy; Haralampos M Moutsopoulos; Jill Buyon; Athanasios G Tzioufas
Journal:  Arthritis Rheum       Date:  2011-09

2.  Preemptive treatment of early donor-specific antibodies with IgA- and IgM-enriched intravenous human immunoglobulins in lung transplantation.

Authors:  Fabio Ius; Murielle Verboom; Wiebke Sommer; Reza Poyanmehr; Ann-Kathrin Knoefel; Jawad Salman; Christian Kuehn; Murat Avsar; Thierry Siemeni; Caroline Erdfelder; Michael Hallensleben; Dietmar Boethig; Nicolaus Schwerk; Carsten Mueller; Tobias Welte; Christine Falk; Axel Haverich; Igor Tudorache; Gregor Warnecke
Journal:  Am J Transplant       Date:  2018-06-03       Impact factor: 8.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.